A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...
A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, researchers reported Saturday in The Lancet. Adobe stock/HealthDay A small ...
Researchers have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers. Researchers at The Johns Hopkins Kimmel Cancer Center have ...
One of the first signs of bladder cancer can be blood in the urine (hematuria). Investigators developed and analyzed the results of a streamlined and simplified DNA-based urine test to improve the ...
BIRMINGHAM, England--(BUSINESS WIRE)--Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, and the University of Birmingham have partnered to develop a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...
Urodynamics plus comprehensive clinical assessment (CCA) showed no superiority over CCA alone in treating women with refractory overactive bladder symptoms. CCA for female incontinence offered equally ...
NEW YORK (Reuters Health) - In a new study, up to half - or more - of older adults on Medicare who had a heart, lung, stomach or bladder test had the same procedure repeated within three years. Those ...
Cellens, a Boston, MA-based cancer diagnostics startup, has raised a $6.5 million seed round. The company is developing a mechanobiology and AI-driven platform, BioFeel, for non-invasive cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results